Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Fundamental Rankings

This page is comprehensive fundamental data for Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.. Fundamentals are ordered by how Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Long term equity investment12,930,698,5430.25522202015-06-30historic
Investment income from associate and joint venture616,624,6980.01217242015-06-30historic
Minority interests gain212,621,0070.0042662015-06-30historic
Comprehensive income attributable to minority shareholders213,006,5620.0042662015-06-30historic
Goodwill3,254,438,5100.06423712015-06-30historic
Cash from minority shareholders of subsidiaries87,721,1950.00173792015-06-30historic
Other non-current liabilities57,780,4370.001141092015-06-30historic
Net income1,516,105,4760.029921152015-06-30historic
Operating profit1,788,034,1210.035291152015-06-30historic
Other current liabilities1,081,654,5910.021351162015-06-30historic
Total comprehensive income1,740,638,5930.034361162015-06-30historic
Total profit1,810,093,6330.035731222015-06-30historic
Long term accounts payable908,518,0840.017931242015-06-30historic
Selling expenses1,280,683,7630.025281392015-06-30historic
Fair value change gain3,219,8846.0E-51442015-06-30historic
Intangible assets2,806,129,2250.055391902015-06-30historic
Interests payable138,041,1650.002721922015-06-30historic
Minority interest2,369,338,0790.046761922015-06-30historic
Construction materials5,551,7101.1E-41922015-06-30historic
Cash paid for other investing activities141,438,3200.002792112015-06-30historic
Total non-current assets28,602,939,5990.564552162015-06-30historic
Cash from other investing activities104,124,2520.002062342015-06-30historic
Cash paid for other financing activities258,619,3020.00512592015-06-30historic
Disposal of fixed assets and others6,469,3581.3E-42712015-06-30historic
Proceeds from sell of investment719,481,6070.01422962015-06-30historic
Other payables1,466,618,9070.028953072015-06-30historic
Payroll payable260,751,6580.005153432015-06-30historic
Long term borrowings1,603,093,0510.031643532015-06-30historic
Financial expenses221,656,1490.004373622015-06-30historic
Cash paid for taxes742,366,5910.014653762015-06-30historic
Interest receivable951,7472.0E-53962015-06-30historic
Other receivables398,337,3300.007864412015-06-30historic
Total liabilities and equity36,346,310,4690.717384482015-06-30historic
Total liabilities16,483,774,2600.325354552015-06-30historic
Non-operating loss8,034,2591.6E-44562015-06-30historic
Notes receivable432,861,7860.008544642015-06-30historic
Purchases of fixed assets and others495,664,5770.009785182015-06-30historic
Capital reserve6,061,526,6360.119645352015-06-30historic
Short term borrowings2,281,914,1200.045045542015-06-30historic
Cash inflows from operating activities7,155,134,8260.141225822015-06-30historic
Cash paid for dividends, profits or interests359,378,9270.007095942015-06-30historic
Fixed assets4,549,360,4690.089796122015-06-30historic
Cash outflows from operating activities6,477,662,9360.127856162015-06-30historic
Refunds of taxes7,887,4201.6E-46412015-06-30historic
Revenue5,921,384,0480.116876522015-06-30historic
Net cash and cash equivalents ending balance2,854,744,2930.056346552015-06-30historic
Total cost of goods sold5,404,281,9140.106676552015-06-30historic
Cash inflows from financing activities2,729,323,5690.053876752015-06-30historic
Deferred tax assets95,422,8930.001886962015-06-30historic
Net cash flows from investing activities-626,742,796-0.012377552015-06-30historic
Net change in cash-155,411,098-0.003077562015-06-30historic
Inventories1,639,958,1080.032378622015-06-30historic
Accounts payable913,179,1030.018028892015-06-30historic
Net cashflow from financing activities-201,497,205-0.003989012015-06-30historic
Prepayment155,031,2110.003069642015-06-30historic
Other current assets5,311,9351.0E-410422015-06-30historic